Literature DB >> 14670140

Fatal propafenone overdoses: case reports and a review of the literature.

Franck Clarot1, Jean Pierre Goullé, Marlène Horst, Emmanuelle Vaz, Christian Lacroix, Bernard Proust.   

Abstract

First synthesized in 1970, propafenone is a frequently used 1C antiarrhythmic drug metabolized into two major metabolites, 5-hydroxypropafenone and norpropafenone. Paradoxically, fatal intoxication is rarely described, and only six cases have been reported in the literature. We report our experience with two patients found dead of self-inflicted poisoning where the propafenone blood concentration was very high (one concentration to our knowledge is one of the highest reported in the literature). At autopsy, no evidence of significant pathological disease were found. Propafenone was detected in blood by gas chromatography-mass spectrometry and by high-performance liquid chromatography using a diode-array detector, respectively, as propafenone artifact and propafenone. Blood propafenone concentrations were 4180 ng/mL and 9123 ng/mL. The literature regarding propafenone pharmacokinetic and intoxication is reviewed, and we discuss the low death rate attributed to this drug in contrast to its frequent use.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14670140     DOI: 10.1093/jat/27.8.595

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  3 in total

1.  Discovering Cross-Reactivity in Urine Drug Screening Immunoassays through Large-Scale Analysis of Electronic Health Records.

Authors:  Jacob J Hughey; Jennifer M Colby
Journal:  Clin Chem       Date:  2019-10-02       Impact factor: 12.167

2.  Full recovery after prolonged resuscitation from cardiac arrest due to propafenone intoxication: A case report.

Authors:  Bingyu Ling; Ping Geng; Dingyu Tan; Joseph Walline
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

3.  Propafenone Overdose: From Cardiogenic Shock to Brugada Pattern.

Authors:  Julio Gil; Bruno Marmelo; Luís Abreu; Hugo Antunes; Luís Ferreira Dos Santos; José Costa Cabral
Journal:  Arq Bras Cardiol       Date:  2018-03       Impact factor: 2.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.